Clinical Trials Logo

Filter by:
NCT ID: NCT00380822 Completed - Clinical trials for Type 2 Diabetes Mellitus

Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Start date: n/a
Phase: Phase 3
Study type: Interventional

To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.

NCT ID: NCT00381147 Completed - Clinical trials for Bronchiolitis Obliterans

Use of Clarithromycin in Mustard-Induced Bronchiolitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

We looked for the effectiveness of low-dose long-term prescription of clarithromycin in mustard-induced chronic pulmonary lesions, especially bronchiolitis obliterans

NCT ID: NCT00381537 Completed - Epilepsy Clinical Trials

Prediction of Childhood Epilepsy Outcome in Bangladesh

Start date: n/a
Phase: N/A
Study type: Interventional

Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.

NCT ID: NCT00382941 Completed - Tendinopathy Clinical Trials

Study of LED Phototherapy for Musculoligamentous Lesions

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether LED phototherapy using combined red and near infrared light (approved: Ministry of Health of Russian Federation No. 29/06070997/1080-00, EUROCAT Certificate No. CP033321-IV) is effective in the treatment of musculoligamentous lesions in physiotherapy practice

NCT ID: NCT00383396 Completed - Pterygia Clinical Trials

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Start date: n/a
Phase: Phase 4
Study type: Interventional

To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

NCT ID: NCT00385957 Completed - HIV Infections Clinical Trials

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Start date: n/a
Phase: Phase 4
Study type: Interventional

The study analyzes the virological response in plasma and non-plasma compartments, as well as the degree and kinetics of immune reconstitution in 70 treatment-naive patients with CD4 < 100/mm3, when they receive treatment with two nucleoside analogs (NRTI) plus one protease inhibitor (PI) compared with 2 NRTI plus one non-nucleoside (NNRTI).

NCT ID: NCT00388232 Completed - COPD Prevalance Clinical Trials

Prevalence of COPD: First Epidemiological Data From a Large Region of Turkey

Start date: n/a
Phase: N/A
Study type: Observational

The study was designed to obtain some baseline data on COPD in Malatya region of Turkey.

NCT ID: NCT00390442 Completed - Clinical trials for Cardiogenic Pulmonary Edema

Out-of-Hospital CPAP for Severe Cardiogenic Pulmonary Edema

Start date: n/a
Phase: Phase 3
Study type: Interventional

In cardiogenic pulmonary edema, Continuous Positive Airway Pressure (CPAP) added to medical treatment improves outcome. The present study was designed to assess the benefit of CPAP as a first line treatment of cardiogenic pulmonary edema in the out-of-hospital environment.

NCT ID: NCT00390988 Completed - Healthy Volunteers Clinical Trials

Capillary and Venous Blood Count Parameters

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to compare capillary blood count parameters with the corresponding venous samples to verify the hypothesis that capillary and venous blood count parameters are equivalent.

NCT ID: NCT00394537 Completed - Bronchoscopy Clinical Trials

Labetalol to Prevent Hypertension and Tachycardia During Fiberoptic Bronchoscopy

Start date: n/a
Phase: Phase 4
Study type: Interventional

Passing a bronchoscope through the airways frequently causes a stress response even though patients are sedated. This stress response is usually an increase in pulse and blood pressure, which may have undesirable effects on the heart and circulation. We plan to give patients labetalol (a beta blocker which reduces pulse and blood pressure) in addition to normal sedation, to patients undergoing bronchoscopy in our department.